Molecular Biology of Cancer PPT: Key Concepts and Practical Insights

Understanding the molecular biology of cancer is crucial for developing targeted therapies and improving patient outcomes. This field explores how genetic and epigenetic changes drive cancer progression, offering fresh insights into treatment strategies. Below, we break down essential concepts with actionable takeaways for researchers and clinicians.

What Drives Cancer at the Molecular Level?

Cancer arises from mutations in key genes, such as oncogenes (e.g., RAS, MYC) and tumor suppressors (e.g., TP53, PTEN). These alterations disrupt normal cell signaling, leading to uncontrolled growth. Epigenetic changes—like DNA methylation and histone modifications—also play a role, often making cancer cells resistant to treatment.

How Do Targeted Therapies Work?

Molecular biology reveals specific vulnerabilities in cancer cells. For example, BCR-ABL fusion proteins in chronic myeloid leukemia (CML) are targeted by tyrosine kinase inhibitors (TKIs) like imatinib. Similarly, HER2 amplification in breast cancer is treated with HER2-targeted antibodies. These therapies exploit molecular differences between cancer and healthy cells.

What Are the Latest Breakthroughs?

Recent advances include CAR-T cell therapy, which genetically engineers immune cells to attack cancer, and checkpoint inhibitors like pembrolizumab. Additionally, liquid biopsies—analyzing circulating tumor DNA—provide real-time monitoring of treatment response. These tools leverage molecular insights to tailor therapies precisely.

How Can Researchers Apply This Knowledge?

To stay current, researchers should focus on:

By focusing on these areas, scientists can advance precision oncology and improve patient care.

A close-up of a red tile pattern, symbolizing the intricate molecular interactions in cancer biology.

Tijolo Cavista Exterior Vermelho — Azulejossola

Tijolo cavista exterior vermelho — Azulejossola

Tijolo cavista exterior vermelho — Azulejossola